$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| FIXED-DOSE COMBINATION OF ALBUTEROL AND BUDESONIDE (PT027) DEMONSTRATED SIGNIFIC | 09 Sep 2021 |
| IMFINZI IMPROVES SURVIVAL IN NSCLC IN POSEIDON | 09 Sep 2021 |
| ULTOMIRIS APPROVED IN EU FOR CHILDREN WITH PNH | 03 Sep 2021 |
| TOTAL VOTING RIGHTS | 01 Sep 2021 |
| FORXIGA APPROVED IN JAPAN FOR CKD | 26 Aug 2021 |
| ALXN1840 WILSON PHASE III MET PRIMARY ENDPOINT | 26 Aug 2021 |
| AZD7442 PROPHYLAXIS TRIAL MET PRIMARY ENDPOINT | 20 Aug 2021 |
| UPDATE ON ULTOMIRIS PHASE III ALS TRIAL | 20 Aug 2021 |
| DIRECTOR/PDMR SHAREHOLDING | 16 Aug 2021 |
| UPDATE ON US REVIEW OF ROXADUSTAT | 11 Aug 2021 |
| ENHERTU HEAD-TO-HEAD TRIAL MEETS PRIMARY ENDPOINT | 09 Aug 2021 |
| FORXIGA APPROVED IN THE EU FOR CKD | 09 Aug 2021 |
| TOTAL VOTING RIGHTS | 02 Aug 2021 |
| SAPHNELO APPROVED IN THE US FOR SLE | 02 Aug 2021 |
| FORM 6-K | 30 Jul 2021 |
| ULTOMIRIS RECOMMENDED IN EU FOR CHILDREN WITH PNH | 26 Jul 2021 |
| DIRECTORATE CHANGE | 22 Jul 2021 |
| DIRECTOR/PDMR SHAREHOLDING | 21 Jul 2021 |
| FORM 6-K | 21 Jul 2021 |
| TOTAL VOTING RIGHTS | 21 Jul 2021 |
